American Vietnamese Biotech Incorporation Balance Sheet Health
Financial Health criteria checks 3/6
American Vietnamese Biotech Incorporation has a total shareholder equity of ₫1,689.8B and total debt of ₫167.0B, which brings its debt-to-equity ratio to 9.9%. Its total assets and total liabilities are ₫1,972.8B and ₫283.0B respectively. American Vietnamese Biotech Incorporation's EBIT is ₫32.4B making its interest coverage ratio 2.1. It has cash and short-term investments of ₫83.9B.
Key information
9.9%
Debt to equity ratio
₫166.96b
Debt
| Interest coverage ratio | 2.1x |
| Cash | ₫83.85b |
| Equity | ₫1.69t |
| Total liabilities | ₫283.03b |
| Total assets | ₫1.97t |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AMV's short term assets (₫1,582.0B) exceed its short term liabilities (₫155.0B).
Long Term Liabilities: AMV's short term assets (₫1,582.0B) exceed its long term liabilities (₫128.0B).
Debt to Equity History and Analysis
Debt Level: AMV's net debt to equity ratio (4.9%) is considered satisfactory.
Reducing Debt: AMV's debt to equity ratio has increased from 2.7% to 9.9% over the past 5 years.
Debt Coverage: AMV's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: AMV's interest payments on its debt are not well covered by EBIT (2.1x coverage).